Viewing Study NCT05800366

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:07 PM
Ignite Modification Date: 2026-01-27 @ 7:22 AM
Study NCT ID: NCT05800366
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-14
First Post: 2023-03-22
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
Sponsor: Jennifer Crombie, MD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
None Lymphoma, Large B-Cell, Diffuse View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lymphoma View
None High-risk diffuse large B-cell Lymphoma View
None Chemotherapy View
None Immunotherapy View